Hak Soo Choi, Ph.D.

Associate Investigator
Gordon Center for Medical Imaging, Mass General Research Institute
Research Staff
Radiology, Massachusetts General Hospital
Associate Professor of Radiology
Harvard Medical School
PhD Japan Advanced Institute of Science & Technology 2004
contrast agents; image-guided surgery; nanoparticles; regenerative medicine; small molecule contrast agents; tissue scaffolds; tissue-specific targeted fluorophores; tumor-targeted fluorophores My research focuses on the development of novel tissue- and organ-specific contrast agents for diagnosis, staging, and treatment of human diseases. Of particular interest is tumor-targeted fluorophores, which can be used for image-guided surgery by specifically visualizing target tissue with high optical properties and by avoiding nonspecific uptake in normal background tissues. During the past decade, we have been systematically probing the relationship among the hydrodynamic diameter, shape, charge, and hydrophobicity of nanoparticles and small molecule contrast agents on in vivo biodistribution and clearance (Nature Biotech. 2007, Nano Lett. 2009, Angew Chem Int Ed. 2011).

Using invisible near-infrared (NIR) fluorescence and 3D molecular modeling, we have defined the relationship among the key independent variables that dictate biodistribution and tissue-specific targeting such as lung and sentinel lymph nodes (Nature Biotech. 2010), human prostate cancers (Nature Nanotech. 2010), and human melanomas (Nature Biotech. 2013). Another project we have been working on is targeting of endocrine glands and their tumors. Currently we have achieved specific targeting on the thyroid/parathyroid glands (Nature Medicine, 2015), pancreas (Theranostics, 2014), thymus, pituitary gland (anterior/posterior separately), and adrenal glands (manuscripts in preparation/review). We have also developed other tissue-specific targeted fluorophores for lymph nodes (Theranostics, 2014), bone and cartilage (Angew Chem Int Ed. 2014), kidneys, liver, lungs, spleen, salivary glands, brown fat, seminal vesicle, and prostate (manuscripts in preparation).

Regenerative medicine with tissue-engineered scaffolds is another area of interest, and we have developed biodegradable NIR scaffolds and cellular trafficking systems for longitudinal monitoring of tissue regeneration (Sci Rep. 2013 and Biomed Mater. 2013). Using dual-channel intraoperative imaging systems, we are currently trying to target cancerous tissue/vasculature/nerve (tumors), cardiovascular diseases, and bone/cartilage/inflammation (rheumatoid arthritis) simultaneously with different colors, which lay the foundation for clinical translation to image-guided surgery.

Research website Publications

CNY-Building #149
149 13th Street
Charlestown, MA 02129